BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 12120242)

  • 1. Early pancreatic cancer.
    Tsuchiya R; Tajima Y; Matsuzaki S; Onizuka S; Kanematsu T
    Pancreatology; 2001; 1(6):597-603. PubMed ID: 12120242
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Incidence of and predictive risk factors for intraductal papillary mucinous neoplasm of the pancreas with ordinary pancreatic cancer.
    Okabayashi T; Nishimori I; Maeda H; Hanazaki K
    J Clin Gastroenterol; 2010 Jan; 44(1):75-6. PubMed ID: 19564793
    [No Abstract]   [Full Text] [Related]  

  • 3. Intraductal tubular adenoma (pyloric gland-type) of the pancreas: a reappraisal and possible relationship with gastric-type intraductal papillary mucinous neoplasm.
    Chetty R; Serra S
    Histopathology; 2009 Sep; 55(3):270-6. PubMed ID: 19723141
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ductal neoplasia of the pancreas: nosologic, clinicopathologic, and biologic aspects.
    Adsay NV; Basturk O; Cheng JD; Andea AA
    Semin Radiat Oncol; 2005 Oct; 15(4):254-64. PubMed ID: 16183479
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Invasive ductal adenocarcinoma of the pancreas may originate from the larger pancreatic duct: a study of 13 tumors less than 2 cm in diameter.
    Suda K; Nobukawa B; Yamasaki S; Abe K; Matsukuma S; Suzuki F
    J Hepatobiliary Pancreat Surg; 2007; 14(3):283-8. PubMed ID: 17520204
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term survival after surgical resection for pancreatic cancer.
    Yoshizawa K; Nagai H; Kurihara K; Sata N; Kawai T; Saito K
    Hepatogastroenterology; 2001; 48(40):1153-6. PubMed ID: 11490822
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Synchronous adenocarcinoma of the sigmoid colon and multifocal intraductal papillary mucinous neoplasm of the pancreas in an elderly patient].
    Mirarchi M; De Raffele E; Lega S; Calculli L; Vaccari S; Cola B
    Chir Ital; 2009; 61(3):357-67. PubMed ID: 19694240
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical significance of frozen section analysis during resection of intraductal papillary mucinous neoplasm: should a positive pancreatic margin for adenoma or borderline lesion be resected additionally?
    Nara S; Shimada K; Sakamoto Y; Esaki M; Kosuge T; Hiraoka N
    J Am Coll Surg; 2009 Nov; 209(5):614-21. PubMed ID: 19854402
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The dichotomy in the preinvasive neoplasia to invasive carcinoma sequence in the pancreas: differential expression of MUC1 and MUC2 supports the existence of two separate pathways of carcinogenesis.
    Adsay NV; Merati K; Andea A; Sarkar F; Hruban RH; Wilentz RE; Goggins M; Iocobuzio-Donahue C; Longnecker DS; Klimstra DS
    Mod Pathol; 2002 Oct; 15(10):1087-95. PubMed ID: 12379756
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Clinicopathological aspects of pancreatic cancer].
    Egawa S; Sunamura M; Abe H; Motoi F; Fukuyama S; Matsuno S
    Gan To Kagaku Ryoho; 2005 May; 32(5):605-11. PubMed ID: 15918558
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biliopancreatic fistula associated with intraductal papillary-mucinous pancreatic cancer: institutional experience and review of the literature.
    Kurihara K; Nagai H; Kasahara K; Kanazawa K; Kanai N
    Hepatogastroenterology; 2000; 47(34):1164-7. PubMed ID: 11020905
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The "new kid on the block": Intraductal papillary mucinous neoplasms of the pancreas: current concepts and controversies.
    Adsay NV
    Surgery; 2003 May; 133(5):459-63. PubMed ID: 12773972
    [No Abstract]   [Full Text] [Related]  

  • 13. [Incidence and characteristics of pancreatic cystic neoplasms].
    Adet A; Miquel R; Bombi JA; Gines A; Fernández-Esparrach G; De Juan C; Ayuso JR; Maurel J; Castells A; Fernández-Cruz L; Navarro S
    Gastroenterol Hepatol; 2010 Oct; 33(8):563-8. PubMed ID: 20850905
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pdcd4 expression in intraductal papillary mucinous neoplasm of the pancreas: its association with tumor progression and proliferation.
    Hayashi A; Aishima S; Miyasaka Y; Nakata K; Morimatsu K; Oda Y; Nagai E; Oda Y; Tanaka M; Tsuneyoshi M
    Hum Pathol; 2010 Nov; 41(11):1507-15. PubMed ID: 20656320
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Anatomy of the head of the pancreas and various limited resection procedures for intraductal papillary-mucinous tumors of the pancreas].
    Kimura W
    Nihon Geka Gakkai Zasshi; 2003 Jun; 104(6):460-70. PubMed ID: 12854493
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Precursor lesions in pancreatic cancer: morphological and molecular pathology.
    Scarlett CJ; Salisbury EL; Biankin AV; Kench J
    Pathology; 2011 Apr; 43(3):183-200. PubMed ID: 21436628
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Secretin receptors in normal and diseased human pancreas: marked reduction of receptor binding in ductal neoplasia.
    Körner M; Hayes GM; Rehmann R; Zimmermann A; Friess H; Miller LJ; Reubi JC
    Am J Pathol; 2005 Oct; 167(4):959-68. PubMed ID: 16192632
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Histologic characteristics of pancreatic intraepithelial neoplasia associated with different pancreatic lesions.
    Recavarren C; Labow DM; Liang J; Zhang L; Wong M; Zhu H; Wang J; Francis F; Xu R
    Hum Pathol; 2011 Jan; 42(1):18-24. PubMed ID: 21056895
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence of FOXP3+ regulatory T cells increases during the progression of pancreatic ductal adenocarcinoma and its premalignant lesions.
    Hiraoka N; Onozato K; Kosuge T; Hirohashi S
    Clin Cancer Res; 2006 Sep; 12(18):5423-34. PubMed ID: 17000676
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular pathogenesis of precursor lesions of pancreatic ductal adenocarcinoma.
    Biankin AV; Kench JG; Dijkman FP; Biankin SA; Henshall SM
    Pathology; 2003 Feb; 35(1):14-24. PubMed ID: 12701679
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.